The UK’s diabetes landscape in the face of tariffs, power shifts and an increasing disease prevalence

News

The End of NHS England: What Comes Next?

Yesterday morning, the Prime Minister blindsided most of Westminster and Whitehall when he announced plans to abolish NHS England (NHSE) as part of wider efforts to cut bureaucracy and streamline government.  This is undeniably a watershed moment for the NHS, with decision-making powers shifting back to the Department of Health and Social Care (DHSC) over

A Renewed Momentum? The England Rare Diseases Action Plan

Today – on Rare Disease Day – the Government unveiled the England Rare Diseases Action Plan 2025. It marks a key step in maintaining momentum in the care and support of those affected by rare conditions before the UK Rare Diseases Framework expires in 2026. The Rare Diseases Action Plan outlines how the health system

From Patient Centricity to Patient Leadership: Pharma’s New Digital Engagement Frontier

Interview with with Jenny Ousbey, originally published in Pharma IQ, to discuss key findings from OVID’s new report on pharma-patient engagement trends and how social media is reshaping the industry’s approach to patient care. Pharma IQ: The report highlights a shift from patient-centric campaigns to patient-led experiences in pharma communications. What do you think has

The Age of Starmer?

As the Labour Party met in Manchester, and listened to powerful and emotive stories from voters, including from a terminal cancer patient, Nathaniel, who wondered “what might have been” had he received cancer treatment on the NHS earlier, the Labour leader, Sir Keir Starmer, took to the stage to promise an end to “sticking plaster

General Election 2024: Soaked Sunak’s Surprise

On a drizzly day in May, a rain-soaked Prime Minster rather bravely, in all senses of the word, stepped outside Downing Street to announce a general election. Reverberating to the sounds of the iconic theme tune of Labour’s 1997 landslide victory, the Prime Minister referenced the NHS only once – in terms of the “record

Rare Disease Action Plan: What’s in store for 2024

There are 300 million people worldwide living with a rare condition. #RareDiseaseDay

Every year, on the last day of February, the global rare disease community comes together to raise awareness and advocate for positive change for the 300 million people worldwide living with a rare disease. To mark Rare Disease Day, the Department of Health and Social Care have published their third Rare Diseases Action Plan for

Labour’s Life Sciences Strategy – more of the same?

a small collection of pills

Whilst the date of the General Election is yet to be announced, both the Conservative and Labour Parties have started 2024 in full campaign mode. Long accused of having no real policies, the latest offering from Labour – a Life Sciences Sector Strategy announced today at an industry roundtable at the Stevenage Bioscience Catalyst –

Contact.

OVID Health
Office 5.09
1 Lyric Square
London
W6 0NB

+44 (0) 330 111 0255
[email protected]

About.

We’re an award-winning specialist healthcare communications agency and founders of the Patient Advocacy & Centricity Tracker tool, as well as the global Patient Partnership Index.

The Health Change Makers.

OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.
Site by XYCO

OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.

Site by XYCO